You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 12, 2026

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
1Georgetown University School of Medicine, Washington, DC, USA.
No abstract available in PubMed .